Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

The move places the company in competition with other direct-to-consumer marketplaces including Hims & Hers Health and Ro.

Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...

Amazon (AMZN) has been steadily expanding into healthcare, and now it’s setting its sights on telehealth companies like Hims ...

Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...

(Reuters) - Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers ...

FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...

The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five ...

In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...